Search Results - "Daignault‐Newton, Stephanie"

Anabolic actions of PTH in murine models: two decades of insights by Zweifler, Laura E., Koh, Amy J., Daignault‐Newton, Stephanie, McCauley, Laurie K.

“…ABSTRACT Parathyroid hormone (PTH) is produced by the parathyroid glands in response to low serum calcium concentrations where it targets bones, kidneys, and…”
Get full text

Long‐term follow‐up after radiotherapy for prostate cancer with and without rectal hydrogel spacer: a pooled prospective evaluation of bowel‐associated quality of life by Seymour, Zachary A., Hamstra, Daniel A., Daignault‐Newton, Stephanie, Bosch, Walter, Michalski, Jeffery, Gay, Hiram A., Pinkawa, Michael

“…Objective To evaluate the long‐term bowel‐associated quality of life (QOL) in men after radiotherapy (RT) for prostate cancer with and without the use of…”
Get full text

Antibiotic use, best practice statement adherence, and UTI rate for intradetrusor onabotulinumtoxin‐A injection for overactive bladder: A multi‐institutional collaboration from the SUFU Research Network (SURN) by Shapiro, Katherine, Anger, Jennifer, Cameron, Anne P., Chung, Doreen, Daignault‐Newton, Stephanie, Ippolito, Giulia M., Lee, Una, Mourtzinos, Arthur, Padmanabhan, Priya, Smith, Ariana L., Suskind, Anne M., Tenggardjaja, Christopher, Van Til, Monica, Brucker, Benjamin M.

“…Introduction Onabotulinumtoxin A (BTX‐A) is a well‐established treatment for overactive bladder (OAB). The American Urological Association (AUA) 2008…”
Get full text

TrueNTH Sexual Recovery Intervention for couples coping with prostate cancer: Randomized controlled trial results by Wittmann, Daniela, Mehta, Akanksha, Bober, Sharon L., Zhu, Ziwei, Daignault‐Newton, Stephanie, Dunn, Rodney L., Braun, Thomas M., Carter, Caroline, Duby, Ashley, Northouse, Laurel L., Koontz, Bridget F., Glodé, L. Michael, Brandon, Jan, Bangs, Rick, McPhail, John, McPhail, Susan, Arab, Lenore, Paich, Kellie, Skolarus, Ted A., An, Lawrence C., Nelson, Christian J., Saigal, Christopher S., Chen, Ronald C., Mulhall, John P., Hawley, Sarah T., Hearn, Jason W. D., Spratt, Daniel E., Pollack, Craig E.

“…BACKGROUND Despite significant sexual dysfunction and distress after localized prostate cancer treatment, patients typically receive only physiologic erectile…”
Get full text

The impact of BRAF mutation status on clinical outcomes with anti‐PD‐1 monotherapy versus combination ipilimumab/nivolumab in treatment‐naïve advanced stage melanoma by Ma, Vincent T., Daignault‐Newton, Stephanie, Waninger, Jessica J., Journey, Sara, Chopra, Zoey, Tezel, Alangoya, Redman, Bruce G., Fecher, Leslie A., Green, Michael D., Alva, Ajjai S., Lao, Christopher D.

“…Nearly half of all metastatic melanoma patients possess the BRAF V600 mutation. Several therapies are approved for advanced stage melanoma, but it is unclear…”
Get full text

Incomplete bladder emptying and urinary tract infections after botulinum toxin injection for overactive bladder: Multi‐institutional collaboration from the SUFU research network by Reynolds, William Stuart, Suskind, Anne M., Anger, Jennifer T., Brucker, Benjamin M., Cameron, Anne P., Chung, Doreen E., Daignault‐Newton, Stephanie, Lane, Giulia I., Lucioni, Alvaro, Mourtzinos, Arthur P., Padmanabhan, Priya, Reyblat, Polina X., Smith, Ariana L., Tenggardjaja, Christopher F., Lee, Una J.

“…Introduction Onabotulinumtoxin A (BTX‐A) is an effective therapy for overactive bladder (OAB), however, adverse events may prevent patients from initiating…”
Get full text

Characterization of glycine‐N‐acyltransferase like 1 (GLYATL1) in prostate cancer by Eich, Marie‐Lisa, Chandrashekar, Darshan Shimoga, Rodriguez Pen᷉a, Maria Del Carmen, Robinson, Alyncia D., Siddiqui, Javed, Daignault‐Newton, Stephanie, Chakravarthi, Balabhadrapatruni V. S. K., Kunju, Lakshmi Priya, Netto, George J., Varambally, Sooryanarayana

“…Background Recent microarray and sequencing studies of prostate cancer showed multiple molecular alterations during cancer progression. It is critical to…”
Get full text

Gleason Pattern 5 Is the Greatest Risk Factor for Clinical Failure and Death From Prostate Cancer After Dose-Escalated Radiation Therapy and Hormonal Ablation by Sabolch, Aaron, B.A, Feng, Felix Y., M.D, Daignault-Newton, Stephanie, M.S, Halverson, Schuyler, B.S, Blas, Kevin, B.S, Phelps, Laura, B.S, Olson, Karin B., Ph.D, Sandler, Howard M., M.S., M.D, Hamstra, Daniel A., M.D., Ph.D

“…Purpose The division of Gleason score (GS) into three categories (2–6, 7, 8–10) may not fully use its prognostic power, as revealed by recent reports…”
Get full text

Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial by Hamstra, Daniel A., MD, PhD, Mariados, Neil, MD, Sylvester, John, MD, Shah, Dhiren, MD, Karsh, Lawrence, MD, Hudes, Richard, MD, Beyer, David, MD, Kurtzman, Steven, MD, Bogart, Jeffrey, MD, Hsi, R. Alex, MD, Kos, Michael, MD, Ellis, Rodney, MD, Logsdon, Mark, MD, Zimberg, Shawn, MD, Forsythe, Kevin, MD, Zhang, Hong, MD, PhD, Soffen, Edward, MD, Francke, Patrick, MD, Mantz, Constantine, MD, Rossi, Peter, MD, DeWeese, Theodore, MD, Daignault-Newton, Stephanie, MS, Fischer-Valuck, Benjamin W., MD, Chundury, Anupama, MD, Gay, Hiram, MD, Bosch, Walter, DSc, Michalski, Jeff, MD, MBA

“…Purpose SpaceOAR, a Food and Drug Administration–approved hydrogel intended to create a rectal–prostate space, was evaluated in a single-blind phase III trial…”
Get full text

Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone by Roca, Hernan, Jones, Jacqueline D, Purica, Marta C, Weidner, Savannah, Koh, Amy J, Kuo, Robert, Wilkinson, John E, Wang, Yugang, Daignault-Newton, Stephanie, Pienta, Kenneth J, Morgan, Todd M, Keller, Evan T, Nör, Jacques E, Shea, Lonnie D, McCauley, Laurie K

“…During tumor progression, immune system phagocytes continually clear apoptotic cancer cells in a process known as efferocytosis. However, the impact of…”
Get full text

Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012 by Hussain, Maha, Daignault-Newton, Stephanie, Twardowski, Przemyslaw W, Albany, Costantine, Stein, Mark N, Kunju, Lakshmi P, Siddiqui, Javed, Wu, Yi-Mi, Robinson, Dan, Lonigro, Robert J, Cao, Xuhong, Tomlins, Scott A, Mehra, Rohit, Cooney, Kathleen A, Montgomery, Bruce, Antonarakis, Emmanuel S, Shevrin, Daniel H, Corn, Paul G, Whang, Young E, Smith, David C, Caram, Megan V, Knudsen, Karen E, Stadler, Walter M, Feng, Felix Y, Chinnaiyan, Arul M

“…Purpose To determine whether cotargeting poly (ADP-ribose) polymerase-1 plus androgen receptor is superior to androgen receptor inhibition in metastatic…”
Get full text

HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone by Day, Kathleen C, Lorenzatti Hiles, Guadalupe, Kozminsky, Molly, Dawsey, Scott J, Paul, Alyssa, Broses, Luke J, Shah, Rajal, Kunja, Lakshmi P, Hall, Christopher, Palanisamy, Nallasivam, Daignault-Newton, Stephanie, El-Sawy, Layla, Wilson, Steven James, Chou, Andrew, Ignatoski, Kathleen Woods, Keller, Evan, Thomas, Dafydd, Nagrath, Sunitha, Morgan, Todd, Day, Mark L

“…Activation of the EGF receptors EGFR (ErbB1) and HER2 (ErbB2) drives the progression of multiple cancer types through complex mechanisms that are still not…”
Get full text

Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer by Roca, Hernan, Hernandez, James, Weidner, Savannah, McEachin, Richard C, Fuller, David, Sud, Sudha, Schumann, Taibriana, Wilkinson, John E, Zaslavsky, Alexander, Li, Hangwen, Maher, Christopher A, Daignault-Newton, Stephanie, Healy, Patrick N, Pienta, Kenneth J

“…Cell plasticity regulated by the balance between the mesenchymal to epithelial transition (MET) and the opposite program, EMT, is critical in the metastatic…”
Get full text

A pooled long-term follow-up after radiotherapy for prostate cancer with and without a rectal hydrogel spacer: impact of hydrogel on decline in sexual quality of life by Seymour, Zachary A., Pinkawa, Michael, Daignault-Newton, Stephanie, Bosch, Walter, Michalski, Jeff M., Gay, Hiram, Hamstra, Daniel A.

“…Purpose The purpose of this study was to analyze the impact of prostate rectal spacers on sexual quality of life (QOL) following external beam radiation…”
Get full text

Adrenergic Blockade Promotes Maintenance of Dormancy in Prostate Cancer Through Upregulation of GAS6 by Decker, Ann M., Decker, Joseph T., Jung, Younghun, Cackowski, Frank C., Daignault-Newton, Stephanie, Morgan, Todd M., Shea, Lonnie D., Taichman, Russell S.

“…Men diagnosed with localized prostate cancer can develop metastases many years after initial treatment, resulting in a poor prognosis. The purpose of this…”
Get full text

Bone marrow macrophages support prostate cancer growth in bone by Soki, Fabiana N, Cho, Sun Wook, Kim, Yeo Won, Jones, Jacqueline D, Park, Serk In, Koh, Amy J, Entezami, Payam, Daignault-Newton, Stephanie, Pienta, Kenneth J, Roca, Hernan, McCauley, Laurie K

“…Resident macrophages in bone play important roles in bone remodeling, repair, and hematopoietic stem cell maintenance, yet their role in skeletal metastasis…”
Get full text

Poor Glycemic Control Increases Dental Risk in a Sri Lankan Population by Steigmann, Larissa, Gunaratnam, Sejal, Giannobile, William V, Van Til, Monica, Daignault-Newton, Stephanie, Herman, William H, Gunaratnam, Naresh, Katulanda, Prasad, Sarma, Aruna V

“…The aim of our study was to investigate the impact of diabetes-related factors on the dental disease outcomes of diabetes patients in Trincomalee, Sri Lanka…”
Get full text

Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment by Seymour, Zachary A., Daignault-Newton, Stephanie, McLaughlin, P.W., Sandler, Howard, Jackson, William, Johnson, Skyler B., Miller, David, Wei, John, Sanda, Martin, Hamstra, Daniel A.

“…•Reported here are patient reported outcomes to 15.8 median years of follow up for initial therapy including brachytherapy, external beam radiotherapy, and…”
Get full text

241 Clinical outcomes of metastatic melanoma patients with liver metastases treated with anti-PD-1 monotherapy versus combination ipilimumab/nivolumab by Ma, Vincent, Griffith, Kent, Waninger, Jessica, Daignault-Newton, Stephanie, Fecher, Leslie, Alva, Ajjai, Lao, Christopher

“…BackgroundRecent studies report of liver metastases (LM) as a poor prognostic factor in patients treated with immune checkpoint inhibitors (ICIs),1 but…”
Get full text

MP57-14 FREQUENCY OF SEXUAL ACTIVITY AND QUALITY OF LIFE AFTER INFLATABLE PENILE PROSTHESIS PLACEMENT by Yi, Yooni, Howland, Rebecca, Daignault-Newton, Stephanie

Get full text